Slide 1: Third Quarter 2011 Earnings Release
EXHIBIT 99.1 Third Quarter October 20, 2011 2011 Earnings Release
Slide 2: Agenda
IDEXGuidance Agenda Fluid Health 2011 2 & Market &Metering Science Assessment Update Dispensing Q&A/ Outlook Equipment Q3 2011 Fire Summary & Safety Q3 2011 Segment Performance
Slide 3: Replay Dial-in Information
Replay Dial IDEX 3 toll–free: Proprietary Information 855.859.2056 & Confidential International: 404.537.3406 Conference ID: #66069195 Log on to: www.idexcorp. com
Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act
Cautionary This of IDEX 4 factors presentation Proprietary that Statement could and & cause Confidential discussion Under those the differences, Private will include Securities including forward Litigation ?those looking presented Reform statements. Act in ourOur most actual recent performance annua
Slide 5: Long Term Growth Strategy Remains Positive
LongProducts Remain Expect Positive Increased Improve Deliver Aftermarket New Innovation IDEX Conversion Commercial Excellence Operational Growth Strategy 5 Term Proprietary organic savings bullish order remains: our exposure focus –penetration growth margin Planning trends New growth on on through
Slide 6: Served Markets Assessment
Long? Chemical Energy Food Agriculture Municipal + 85%+ Current Rest North Europe IDEX Healthcare Chem/Industrial 6 / ?+ of European Governmental US Aftermarket Chem U.S. Mid Global OEM Both International Rescue /America Served Proprietary Markets of Term Beverage the Revenue Muni IDEX and /expansio
Slide 7: IDEX Financial Performance
Total $500 $477 Organic: Operating 70 25% 18.3% * Q3 42% EPS* Free $0.50 $0.71 $0.00 $1.00 59% $100 IDEX 2011 2010 $54 $86 Outstanding 7 EPS bps Cash 20% Growth $250 $374 $50 Revenue Q3 Proprietary /17.6% expansion Op 9% $0 2011 15% Margin* Flow $0 Margin free10% Financial cash &data Confidential fl
Slide 8: Fluid & Metering Summary
Fluid Total Organic: Operating 160 $195 $300 $170 25% 2011 2010 Acquisition Q3 Adjusted globally * 16%Sales Summary IDEXbps 20% $179 $200 $202 Orders Revenue & Op expansion Metering stable, 6% 16% Mix: organic 15% Margin* $100 Margin organic?Fx : Organic 10% US Proprietary+3% $0 order &data revenuem
Slide 9: Health & Science Summary
Health $173 Total Organic: $300 $177 25% Operating 2011 380 [Graphic 2010 19.2% 23.0% Acquisition Q3 Excluding New Industrial, Completed * CVISales Summary IDEXbps 20% products $109 $200 $111 Orders Revenue &Op compression 6% 4% Appears Mix: Science 15% Margin* environmental, CVI $100 CVI Margin +54
Slide 10: Dispensing Summary
Dispensing $31 Total Organic: $50 $26 120 20% 10.2% 2011 2010 Acquisition * 10 IDEXSales $24 $25 bps 10% Orders Revenue 9.0% Operating Q3 Eastern Holding Op compression Structural$0 Summary23% (11)% Mix: 0% Margin* Margin ?Fx Proprietary Europe, share Organic actions margins :in +6% Asiadata N.A.;To
Slide 11: Fire & Safety Summary
FireSummary $81 2011 Acquisition Total $0 $30 $60 $90 Organic: $74 Operating 30% 25.4% 2010 Q3 Rescue BAND North * 11 IDEXSales $70 $67 Great&20% 2011 Orders Revenue American 25.4% Safety/Diversified IT winning Op13% 6% Mix: 10% Margin* growing Margin ?Fx : Organic performance Proprietaryinternation
Slide 12: Outlook: Q4 and FY 2011 Guidance Summary
Outlook: Q4 FY Adjusted Organic Positive Other Tax Free EPS IDEX 12 2011 rate estimate Cash modeling Proprietary revenue Fx =2011 EPS Flow 30% impact excludes estimate Guidance Cap items will growth &ofEx exceed Confidential ~2% future range: $36? of in Summary to the 4% net 38M restructuring, sales
Slide 13: Q&A
IDEX Proprietary & Confidential Q&A 13